Thermo Fisher Scientific Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 56c, Revenues Beat
April 29, 2021 6:08 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $7.21, $0.56 better than the analyst estimate of $6.65. Revenue for the quarter came in at $9.91 billion versus the consensus estimate of $9.72 billion.
First Quarter 2021 Highlights
First quarter revenue increased 59% to $9.91 billion.First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88.First quarter adjusted EPS increased 145% to $7.21.Continued significant role in enabling the COVID-19 response, helping to scale vaccine production and supporting testing globally, and accelerated growth in the base business.Strong start to the year in terms of product launches including two Thermo... More